Metabolomics and bladder cancer

Matthew E. Hyndman, Jeffrey K. Mullins, Trinity J. Bivalacqua

Research output: Contribution to journalReview article


Diagnosis of bladder cancer is primarily made based on clinical presentation and then by direct visualization with cystoscopy. Despite the massive investments recently made to identify urinary-based assays that are able to diagnosis urothelial carcinoma, urine cytology and cystoscopy still remain the gold standard. Recently proof of principle studies have shown that noninvasive urine-based metabolomics, using high pressure liquid chromatography (HPLC) and nuclear magnetic resonance (NMR), may be able to accurately diagnosis bladder cancer. This review discuses the published studies investigating metabolomics and bladder cancer and the future potential of this developing field.

Original languageEnglish (US)
Pages (from-to)558-561
Number of pages4
JournalUrologic Oncology: Seminars and Original Investigations
Issue number5
StatePublished - Sep 1 2011


  • Bladder cancer
  • Cystoscopy
  • Cytology
  • Diagnosis
  • HPLC
  • Metabolomics
  • NMR
  • Review
  • Urine

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint Dive into the research topics of 'Metabolomics and bladder cancer'. Together they form a unique fingerprint.

  • Cite this